Osteometer and Cortecs in osteoporosis collaboration
This article was originally published in Clinica
Executive Summary
Development of a rapid, whole-blood diagnostic for the detection of osteoporosis is the aim of a profit-sharing collaborative agreement between Cortecs (UK) and Osteometer BioTech (Denmark). Using Osteometer's Cross-Laps bone resorption marker technology and Cortecs' rapid diagnostic technologies, the companies aim to develop a point-of-care product to detect collagen breakdown - a key indicator of osteoporosis.